Abstract
Background: Epilepsy is a chronic brain condition affecting over 50 million people worldwide. Several new anti-seizure medications (ASMs) have been introduced to treat epilepsy in recent decades.
Objective: Nearby the specific therapeutic action, ASMs, like other types of pharmacotherapy, can produce various side effects. In this review, we shall analyze the different pharmaceutical classes of ASMs, their mechanism of action, and their interaction with the respiratory system.
Methods: This manuscript is based on a retrospective review of English publications indexed by Pubmed, UpToDate and datasheets published by the European Medicines Agency and the Food and Drug Administration (FDA), using various terms reminiscent of ASMs and pulmonary function.
Results: ASMs act on organism homeostasis in different ways, acting on lung function directly and indirectly and playing a protective or damaging role. A damaging direct lung involvement ranged from infections, hypersensitivity reactions, and respiratory depression to other structured pulmonary diseases. Meanwhile, a damaging indirect effect, might be constituted by pulmonary artery hypertension. On the other hand, a protective effect might be the expression of developmental processing, decreasing airway remodelling in asthma patients, vascular remodelling in pulmonary hypertension and, nonetheless, anti-inflammatory and immunomodulatory actions.
Conclusion: An adequate awareness of ASMs effects on the respiratory system seems essential for better managing frail individuals or/and those predisposed to respiratory disorders to improve our patients' clinical outcomes.
Keywords: Anti-seizure medications (ASMs), antiepileptic drugs (AEDs), respiratory function, epilepsy, lung function, pulmonary disease.
Current Respiratory Medicine Reviews
Title:Unravelling the Impact: Pulmonary Side Effects of Anti-Seizure Medications
Volume: 21 Issue: 1
Author(s): Ambra Butera, Martina Pirrone, Arianna Santina Accetta, Carla Consoli, Antonio Gennaro Nicotera*Laura Turriziani
Affiliation:
- Unit of Child Neurology and Psychiatry, Department of Human Pathology of the Adult and Developmental Age “Gaetano Barresi”, University of Messina, Italy
Keywords: Anti-seizure medications (ASMs), antiepileptic drugs (AEDs), respiratory function, epilepsy, lung function, pulmonary disease.
Abstract:
Background: Epilepsy is a chronic brain condition affecting over 50 million people worldwide. Several new anti-seizure medications (ASMs) have been introduced to treat epilepsy in recent decades.
Objective: Nearby the specific therapeutic action, ASMs, like other types of pharmacotherapy, can produce various side effects. In this review, we shall analyze the different pharmaceutical classes of ASMs, their mechanism of action, and their interaction with the respiratory system.
Methods: This manuscript is based on a retrospective review of English publications indexed by Pubmed, UpToDate and datasheets published by the European Medicines Agency and the Food and Drug Administration (FDA), using various terms reminiscent of ASMs and pulmonary function.
Results: ASMs act on organism homeostasis in different ways, acting on lung function directly and indirectly and playing a protective or damaging role. A damaging direct lung involvement ranged from infections, hypersensitivity reactions, and respiratory depression to other structured pulmonary diseases. Meanwhile, a damaging indirect effect, might be constituted by pulmonary artery hypertension. On the other hand, a protective effect might be the expression of developmental processing, decreasing airway remodelling in asthma patients, vascular remodelling in pulmonary hypertension and, nonetheless, anti-inflammatory and immunomodulatory actions.
Conclusion: An adequate awareness of ASMs effects on the respiratory system seems essential for better managing frail individuals or/and those predisposed to respiratory disorders to improve our patients' clinical outcomes.
Export Options
About this article
Cite this article as:
Butera Ambra, Pirrone Martina, Accetta Santina Arianna, Consoli Carla, Nicotera Gennaro Antonio*, Turriziani Laura, Unravelling the Impact: Pulmonary Side Effects of Anti-Seizure Medications, Current Respiratory Medicine Reviews 2025; 21 (1) . https://dx.doi.org/10.2174/011573398X279958240131101144
DOI https://dx.doi.org/10.2174/011573398X279958240131101144 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multivalent Vancomycins and Related Antibiotics Against Infectious Diseases
Current Pharmaceutical Design Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design Dendrimer-drug Conjugates in Drug Delivery and Targeting
Pharmaceutical Nanotechnology COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients
Current Vascular Pharmacology Recent Insights in Pre-mRNA 3-End Processing Signals and Proteins in the Protozoan Parasite Entamoeba histolytica
Infectious Disorders - Drug Targets GOQDs and GOQDs-NS-doped Carbocatalysts: A Concise Study on Production and Use in One-pot Green MCRs
Current Organic Synthesis The COVID-19 and Munchausen Syndrome
Coronaviruses Vpu: A Multifunctional Protein that Enhances the Pathogenesis of Human Immunodeficiency Virus Type 1
Current HIV Research Accumulation Effects of 3-N-Benzyloxycarbonyl-β-aminobutyric Salicylate on the Alkaloids in <i>Catharanthus roseus</i> Cells
Letters in Drug Design & Discovery False Positives in the Early Stages of Drug Discovery
Current Medicinal Chemistry Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm
Current Pharmaceutical Design Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review
Coronaviruses Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Screening of Extremophile Microalgae Isolated from High Background Radiation Areas as Source of Bioactive Materials
Current Bioactive Compounds Intervertebral Disc Engineering through Exploiting Mesenchymal Stem Cells: Progress and Perspective
Current Stem Cell Research & Therapy Alternatives to Conventional Vaccines - Mediators of Innate Immunity
Current Drug Targets The Role of CO-RADS Scoring System in the Diagnosis of COVID-19 Infection and its Correlation with Clinical Signs
Current Medical Imaging Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors
Current Medicinal Chemistry